30 Year 3: Blood Transfusion exam questions on Master Blood Transfusion MCQs: Coagulation & Hematology for medical students. Includes MCQs, answers, explanation
This MCQ set contains 30 questions on Master Blood Transfusion MCQs: Coagulation & Hematology in the Year 3: Blood Transfusion unit. Each question includes the correct answer and a detailed explanation for active recall and exam preparation.
Correct answer: A – Factor VIII
Hemophilia A = Factor VIII deficiency; Hemophilia B = Factor IX deficiency (Christmas disease).
Correct answer: B – Factor VII deficiency
Factor VII is only in the extrinsic pathway (measured by PT); its deficiency prolongs PT while leaving aPTT normal.
Correct answer: C – Liver disease
Liver disease impairs synthesis of multiple coagulation factors, prolonging both pathways.
Correct answer: D – Platelet concentrate
Thrombocytopenia = low platelets; replacing platelets directly addresses the bleeding cause.
Correct answer: A – All of the above
The crossmatch detects any antibody-antigen reaction between donor RBCs and recipient serum.
Correct answer: B – O negative RBCs
O negative is the universal donor — no A, B, or Rh antigens to trigger reactions.
Correct answer: D – Factor IX
Cryo contains: fibrinogen, Factor VIII, Factor XIII, vWF, and fibronectin. Factor IX is NOT in cryoprecipitate.
Correct answer: B – Antibodies bound to patient's RBCs
DAT detects IgG or complement already coating the patient's own RBCs in vivo.
Correct answer: C – Acute hemolytic reaction
ABO-incompatible transfusion causes massive intravascular hemolysis, DIC, renal failure — rapidly fatal.
Correct answer: D – D-dimer
D-dimer is highly sensitive for DIC — elevated whenever clot formation and lysis are simultaneously occurring.
Correct answer: C – Prolonged bleeding time and aPTT
vWF is needed for platelet adhesion (bleeding time) and carries Factor VIII (aPTT).
Correct answer: D – Vitamin K antagonism
Warfarin inhibits Vitamin K epoxide reductase, blocking activation of factors II, VII, IX, and X.
Correct answer: B – aPTT
Heparin potentiates antithrombin III; therapeutic target is 1.5–2.5× normal aPTT.
Correct answer: C – 5–10 days after starting heparin
HIT is immune-mediated via antibodies against heparin-PF4 complexes.
Correct answer: A – Kell
Kell antigens are highly immunogenic and clinically the next most significant after ABO and Rh.
Correct answer: B – 100% volume in 24h
Replacement of the entire blood volume (~5L) within 24 hours, or 10 units of RBCs.
Correct answer: A – 1:1:1
Evidence-based damage control resuscitation uses a balanced 1:1:1 ratio.
Correct answer: B – Thrombotic disorders
ATIII is a natural anticoagulant; its deficiency causes thrombophilia.
Correct answer: C – Von Willebrand disease
vWD affects ~1% of the population — the most common inherited bleeding disorder worldwide.
Correct answer: B – Resistance to activated protein C
Factor V Leiden makes Factor Va resistant to cleavage by activated Protein C, causing thrombophilia.
Correct answer: C – Donor antibodies against recipient leukocytes
Donor anti-HLA or anti-HNA antibodies activate recipient neutrophils in the lung, causing non-cardiogenic pulmonary edema within 6 hours.
Correct answer: B – 5 days
Stored at 20–24°C with agitation; limited to 5 days due to bacterial contamination risk.
Correct answer: C – Factor VII
Factor VII belongs exclusively to the extrinsic pathway. Intrinsic: XII, XI, IX, VIII.
Correct answer: A – Protein C
Protein S enhances activated Protein C's ability to degrade Factors Va and VIIIa.
Correct answer: B – Liver disease
The liver synthesizes nearly all coagulation factors — liver disease is the most common acquired coagulopathy globally.